BOSTON (December 21, 2018) – Holland & Knight advised Express Scripts Holding Company (NASDAQ: ESRX) on the healthcare regulatory and licensing aspects of its $54 billion sale to Cigna Corporation (NYSE: CI). The deal closed on December 20.
The combination of Cigna, a leading global health insurance company, with Express Scripts, the largest pharmacy benefit management organization in the United States, integrates two complementary healthcare service companies. Together, they are positioned to deliver better care, expanded choice and drive down healthcare costs.
Holland & Knight Partner Jeffrey Mittleman led the firm's representation of Express Scripts along with Partners Courtney Groh and Jenna Bigornia and Associates Ilenna Stein, David Weissman, Will Pezzolo, Ben Tso and Andrew Namkung.
Centerview Partners LLC and Lazard Frères & Co. LLC acted as financial advisors to Express Scripts.
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.